Attendee Quick Reference Guide

Past Webcasts

Link to Archived Webinars
(Requires Member Login. After Login - Click on "AMP Web Library" in the Left Navigation Column.)

Instructions for Accessing Archived Webinars (AMP members only have access)







Association for Molecular Pathology

Future Webcasts

2016 Webcasts

For AMP Webcasts that offer Continuing Education Credit:

AMP is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E.® Program.

Individual attendees requesting P.A.C.E.® credit should use the form provided below. If you are viewing the webcast in a group setting, please use the P.A.C.E.® Group Attendance Roster, below. Each group participant is required to print and sign his or her name and email address to verify attendance. Once the webcast has concluded, the designated "Site Coordinator" must email this group attendance form to Kathleen Carmody, P.A.C.E.® Coordinator, in order for each participant to receive P.A.C.E.® credit.


Please contact Kathleen Carmody via email with any questions.

New Report from AMP:
"The Spectrum of Clinical Utilities in Molecular Pathology Testing Procedures for Inherited Conditions and Cancer"

The Association for Molecular Pathology (AMP) has set important standards for how clinical utility is defined and assessed as it relates to molecular diagnostic testing procedures for inherited conditions and cancer. The report, published in the September issue of The Journal of Molecular Diagnostics (JMD), recommends a fundamental shift to achieve the proactive, patient-centered approach necessary for modern healthcare.


In the manuscript, the AMP Framework for the Evidence Needed to Demonstrate (FEND) Clinical Utility task force makes numerous specific recommendations in the following areas:

  • Adopting patient-centered definitions of clinical utility
  • Recognizing an accurate diagnosis has inherent clinical utility
  • Recognizing that clinical utility for molecular diagnostics is context dependent
  • Supporting multiple modalities of evidence generation, including appropriate alternatives to randomized clinical trials
  • Utilizing a modified ACCE Model
  • Recognizing the critical role of the molecular professional
  • Supporting professional organization-driven practice guidelines




Certificate of Attendance


PACE Evaluation Form


PACE Group Attendance Form



Part 3: Clinical Utility for Inherited Conditions

Tuesday, October 11, 2016 at 1:00 PM (ET)

Presenters: Stephanie Hallam, PhD, MBA, Victoria M. Pratt, PhD, and Elaine Lyon, PhD


AMP is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E.® Program.